StockData
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Pharvaris N.V.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026
$29.77+2.03 (+7.32%)

Close on Oct 19, 2026

Pharvaris statistics

Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasurePharvarisIndustry median
Market Cap€1.73B€878.09M
Enterprise Value€1.42B€706.41M

Income (trailing twelve months)

MeasurePharvarisIndustry median
Operating Income-€173.71M-€54.01M
Pretax Income-€173.71M-€47.40M
EBITDA-€173.71M-€42.85M
EPS (Diluted)-2.97 EUR-0.55 EUR

Balance sheet

MeasurePharvarisIndustry median
Cash & Short-Term Investments€318.28M€199.29M
Net Cash (Debt)€318.28M€111.50M
Net Cash Per Share4.88 EUR1.53 EUR

Cash flow (trailing twelve months)

MeasurePharvarisIndustry median
Operating Cash Flow-€137.07M-€42.16M
Capital Expenditures-€164.62K-€2.34M
Free Cash Flow-€137.24M-€52.90M
FCF Per Share-2.10 EUR-0.48 EUR

Efficiency

MeasurePharvarisIndustry median
Employee Count80,000304

Dividends and yields

MeasurePharvarisIndustry median
FCF Yield-7.91%-13.6%

Shares

MeasurePharvarisIndustry median
Shares Outstanding65,210,60099,540,150
Shares Change (YoY)9.51%5.61%
Float63,635,50078,574,400
Shares Held by Insiders2.42%9.05%

Taxes

MeasurePharvarisIndustry median
Income Tax€1.99M€80.00K

Scores

MeasurePharvarisIndustry median
Altman Z-Score32.761.13

Calculated by StockData from Pharvaris's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.